Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BME/ATRY stock hub

BME/ATRY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/ATRYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

207.2M

Madrid Stock Exchange

Market data

Price

Recent price action with selectable time range.

BME/ATRYBME/ATRY

—

Loading chart…

In the news

Latest news · BME/ATRY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E47.2

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-27.5

P25 n/aP50 n/aP75 n/a

ROIC-2.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/ATRY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

EUR

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	758
Employees Change	-1,287%
Employees Change Percent	-62.93
Enterprise value	EUR 451.6M
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	ES0105148003
Last refreshed	2026-05-10
Market cap	EUR 207.2M
Price	EUR 2.73
Price currency	EUR
Rev Per Employee	219,990.85x
Sector	Healthcare
Sic	8071
Symbol	bme/ATRY
Website	https://www.atryshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-48.4%
EV Earnings	-4.5x
EV/EBITDA	39.49x
EV/FCF	-56.1x
EV/Sales	3.13x
FCF yield	-3.88%
Forward P/E	47.22x
P/B ratio	1.36x
P/S ratio	1.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.21%
EBITDA Margin	4.36%
Gross margin	17.27%
Gross Profit	EUR 24.9M
Gross Profit Growth	-55.77%
Gross Profit Growth3 Y	-23.39%
Gross Profit Growth5 Y	-11.37%
Net Income	EUR -100.3M
Net Income Growth Years	0%
Pretax Margin	-38.94%
Profit Margin	-69.5%
Profit Per Employee	EUR -152,890
ROA	-1.21
Roa5y	-0.62
ROCE	-5.11
ROE	-27.46
Roe5y	-14.26
ROIC	-2.62
Roic5y	-1.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.46%
Cagr3y	-18.26%
Cagr5y	-21.23%
EPS Growth Years	0
Revenue Growth	7x
Revenue Growth Q	5.08x
Revenue Growth Years	0x
Revenue Growth3 Y	-11.91x
Revenue Growth5 Y	-3.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.27
Assets	EUR 494M
Cash	EUR 13.6M
Current Assets	EUR 234M
Current Liabilities	EUR 290.4M
Debt	EUR 257.9M
Debt EBITDA	EUR 22.55
Debt Equity	EUR 1.7
Debt FCF	EUR -32.03
Equity	EUR 152M
Interest Coverage	-0.55
Liabilities	EUR 342.1M
Long Term Assets	EUR 260.1M
Long Term Liabilities	EUR 51.7M
Net Cash	EUR -244.3M
Net Cash By Market Cap	EUR -118
Net Debt EBITDA	EUR 38.85
Net Debt Equity	EUR 1.61
Tangible Book Value	EUR -50.4M
Tangible Book Value Per Share	EUR -0.66
WACC	6.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.81
Inventory Turnover	62.74
Net Working Capital	EUR 153.9M
Quick ratio	0.16
Working Capital	EUR -56.5M
Working Capital Turnover	EUR -4.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.46%
200-day SMA	2.91
3Y total return	-45.4%
50-day SMA	2.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.67%
All Time High	11.25
All Time High Change	-75.73%
All Time High Date	2021-08-30
All Time Low	1.29
All Time Low Change	111.96%
All Time Low Date	2016-12-27
ATR	0.1
Beta	0.55
Beta1y	0.33
Beta2y	0.61
Ch YTD	-6.83
High	2.79
High52	3.59
High52 Date	2025-10-08
High52ch	-23.96%
Low	2.73
Low52	2.48
Low52 Date	2025-06-24
Low52ch	10.08%
Ma50ch	-4.28%
Price vs 200-day SMA	-6.12%
RSI	39.51
RSI Monthly	39.18
RSI Weekly	43.02
Sharpe ratio	-0.05x
Sortino ratio	0.11
Total Return	0.04%
Tr YTD	-6.83
Tr1m	-3.53%
Tr1w	-0.91%
Tr3m	-7.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -10.4M
Operating margin	-7.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38,413,369%
Net Borrowing	11,320,000
Shares Insiders	7.56%
Shares Institutions	15.01%
Shares Out	75,906,035
Shares Qo Q	-0.65%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8.1M
Average Volume	83,074.85x
Bv Per Share	2
CAPEX	EUR -6.5M
Ch1m	-3.53
Ch1w	-0.91
Ch1y	-7.46
Ch3m	-7.14
Ch3y	-45.4
Ch5y	-69.67
Ch6m	-7.46
Change	-0.55%
Change From Open	-2.15
Close	2.75
Days Gap	1.64
Depreciation Amortization	16,687,000
Dollar Volume	232,560.5
Earnings Date	2026-06-22
EBIT	EUR -10.4M
EBITDA	EUR 6.3M
EPS	EUR -1.32
F Score	2
FCF	EUR -8.1M
FCF EV Yield	-1.78x
FCF Per Share	EUR -0.11
Financing CF	11,284,000
Fiscal Year End	December
Founded	2,007
Goodwill	132,448,000
Income Tax	EUR -576,000
Investing CF	-12,591,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Ma150	2.94
Ma150ch	-6.98%
Ma20	2.89
Ma20ch	-5.44%
Net CF	-2,866,000
Next Earnings Date	2026-06-22
Open	2.79
Position In Range	0
Ppne	43,724,000
Price Date	2026-05-08
Price EBITDA	EUR 32.96
Relative Volume	1x
Revenue	144,314,000x
Tax By Revenue	-0.4x
Tr6m	-7.46%
Volume	85,187
Z Score	-0.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BME/ATRY pay a dividend?

Capital-return profile for this ticker.

Performance

BME/ATRY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/ATRY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.0%

Share of float held by funds and institutions

Insider ownership

+7.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BME/ATRY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.5

Neutral momentum band

Price vs 200-day MA

-6.1%

50/200-day relationship not available

Beta (5Y)

0.55

Less volatile than the market

Sharpe ratio

-0.05

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/ATRY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/ATRY stock rating?

bme/ATRY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/ATRY analysis?

The full report lives at /stocks/bme/ATRY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/ATRY?

The latest report frames bme/ATRY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/ATRY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.